&nbsp;

dapLungJuly18.xml

Jul 2018

Document

dapLungJuly18.html

Jul 2018

Document

dapProstateJuly18.xml

Jul 2018

Document

dapProstateJuly18.html

Jul 2018

Regimen

DURV

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation

Drugs Used:

durvalumab

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

FC+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FC(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

fludarabine (Unfunded),

cyclophosphamide

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

mitoXANTRONE,

fludarabine (Unfunded),

cyclophosphamide

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FLUD+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

fludarabine

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FLUD(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

fludarabine (Unfunded)

Quick Link(s):

Regimen Monograph

May 2019

Regimen

DENO

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

denosumab (Unfunded)